Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01059838 · ClinicalTrials.gov registry record · NA

Speech Perception for Children With Cochlear Implants

A NA study of Hearing Loss, sponsored by Mayo Clinic.

Completed
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT01059838: Completed NA study of Hearing Loss, sponsored by Mayo Clinic.

NCT01059838 is a NA study of Hearing Loss that has completed, run by Mayo Clinic. The registered enrollment target is 30 participants, below the 6,120-participant average among 58 other Hearing Loss trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01059838, a NA study of Hearing Loss, has completed, sponsored by Mayo Clinic.

COMPLETED
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to determine whether speech recognition in noise can be improved by the addition of a special listening program to the sound processor. Thus we propose to assess speech perception in noise for pediatric cochlear implant patients using both their everyday listening program as well an ASC program.

Conditions Studied

Interventions

  • BEHAVIORAL sentence recognition

Study Locations (1)

Minnesota

  • Mayo Clinic - Rochester

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2009-10
Est. Completion 2010-10
Phase NA
Mayo Clinic

2,844 total trials

What the finished NCT01059838 record still lists

NCT01059838 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 6,120-participant average among 58 other Hearing Loss trials with a reported enrollment target (100% lower).

The record links to 1 condition, with Hearing Loss appearing as the primary indexed condition, and to 1 intervention - of which sentence recognition is the first listed.

NCT01059838 reports a single indexed study location in Minnesota.

Frequently Asked Questions

What is clinical trial NCT01059838 about?

NCT01059838 is a clinical study titled "Speech Perception for Children With Cochlear Implants". The purpose of this study is to determine whether speech recognition in noise can be improved by the addition of a special listening program to the sound processor. Thus we propose to assess speech perception in noise for pediatric cochlear implant patients using both their everyday listening progra...

What is the current status of trial NCT01059838?

This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2009-10. Estimated completion is 2010-10.

What conditions does trial NCT01059838 study?

This clinical trial studies the following conditions: Hearing Loss.

What interventions are being tested in trial NCT01059838?

The interventions under investigation include: sentence recognition (BEHAVIORAL).

Who is sponsoring clinical trial NCT01059838?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01059838 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hearing Loss

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01059838's enrollment target sits among peer trials

30 49th of 58 higher than 9 of 58 other Hearing Loss trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Hearing Loss trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00977977 · 30 participants · Phase 2

    Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy

  • NCT01459107 · 30 participants · Phase 2

    Human Upper Extremity Allotransplantation

  • NCT01666080 · 30 participants · NA

    Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)

  • NCT01720836 · 30 participants · Phase 1

    Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01059838, the US trial registry maintained by the National Library of Medicine. NCT01059838 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.